BIOLOGICAL SIGNIFICANCE OF BETA hCG, HLA AND OTHER MEMBRANE ANTIGEN EXPRESSION ON BLADDER TUMOURS AND THEIR RELATIONSHIP TO TUMOUR INFILTRATING LYMPHOCYTES (TIL)
- 1 August 1989
- journal article
- research article
- Published by Wiley in International Journal of Immunogenetics
- Vol. 16 (4-5) , 381-390
- https://doi.org/10.1111/j.1744-313x.1989.tb00485.x
Abstract
Expression of beta human chorionic gonadotropin (.beta.hCG) by bladder tumours has been shown to be associated with increased metastases and resistance to treatment with radiotherapy and chemotherapy. Preliminary results from typing frozen tumours using monoclonal antibodies against HLA determinants show reduced or lost expression of one or more antigens in two thirds of patients studied with a trend for more malignant behaviour and inability to generate tumour infiltrating lymphocyte expression using Interleukin-2 in those patients whose tumours demonstrate loss. In this series .beta.hCG expression was only seen in a subgroup of those demonstrating loss of HLA antigen expression. Studies of .beta.hCG secreting bladder cancer cell lines showed that is was possible to induce class II HLA antigen expression with gamma Interferon, and that this treatment but not alpha Interferon reduced .beta.hCG production by the cell line.This publication has 19 references indexed in Scilit:
- Prediction of Response to Radiotherapy in Invasive Bladder CancerBritish Journal of Urology, 1990
- Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic MelanomaNew England Journal of Medicine, 1988
- Development of Bladder Tumour Containing HPV Type 11 DNA after Renal TransplantationBritish Journal of Urology, 1988
- The HLA system: structure and function.Journal of Clinical Pathology, 1987
- Identification of Human Papillomavirus Type 18 E6 Polypeptide in Cells Derived from Human Cervical CarcinomasJournal of General Virology, 1987
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced CancerNew England Journal of Medicine, 1987
- HUMAN CHORIONIC GONADOTROPHIN AND SUBUNITS—HETEROGENEITY IN SERUM OF MALE PATIENTS WITH TUMOURS OF THE GENITAL TRACTClinical Endocrinology, 1985
- Monoclonal Antibodies for Analysis of the HLA SystemImmunological Reviews, 1979
- EXPRESSION OF HLA SYSTEM ANTIGENS ON PLACENTATransplantation, 1976